Vascular safety of erenumab for migraine prevention

OBJECTIVE: To examine the cardiovascular, cerebrovascular, and peripheral vascular safety of erenumab across migraine prevention studies. METHODS: Vascular adverse events (AEs) and blood pressure data were integrated across 4 double-blind, placebo-controlled studies of erenumab and their open-label...

詳細記述

保存先:
書誌詳細
出版年:Neurology
主要な著者: Kudrow, David, Pascual, Julio, Winner, Paul K., Dodick, David W., Tepper, Stewart J., Reuter, Uwe, Hong, Frank, Klatt, Jan, Zhang, Feng, Cheng, Sunfa, Picard, Hernan, Eisele, Osa, Wang, Julie, Latham, Jonathan N., Mikol, Daniel D.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080286/
https://ncbi.nlm.nih.gov/pubmed/31852816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008743
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料